Clinical Trial Update: MUK Nine b: OPTIMUM Treatment Protocol [Phase 2]

View source ↗

Summary

Phase 2 OPTIMUM treatment protocol update for MUK Nine b in multiple myeloma; the trial is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Leeds | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING